Report overview
This report contains market size and forecasts of Constrained Peptide Drugs in Global, including the following market information:
Global Constrained Peptide Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Constrained Peptide Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cyclic Peptides Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Constrained Peptide Drugs include Aileron Therapeutics, Inc, Bicycle Therapeutics, PLC, Polyphor Limited, Protagonist Therapeutics, Inc, Santhera Pharmaceuticals Holding, Union Chimique Belge S.A. (UCB), Pepscan Therapeutics B.V., Pepticom Ltd. and PeptiDream, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Constrained Peptide Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Constrained Peptide Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Constrained Peptide Drugs Market Segment Percentages, by Type, 2021 (%)
Cyclic Peptides
Disulfide-Rich Peptides (DRPs)
Global Constrained Peptide Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Constrained Peptide Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Institute of Biology
Others
Global Constrained Peptide Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Constrained Peptide Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Constrained Peptide Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Constrained Peptide Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aileron Therapeutics, Inc
Bicycle Therapeutics, PLC
Polyphor Limited
Protagonist Therapeutics, Inc
Santhera Pharmaceuticals Holding
Union Chimique Belge S.A. (UCB)
Pepscan Therapeutics B.V.
Pepticom Ltd.
PeptiDream, Inc.
CPC Scientific Inc.
Creative Peptides
Bio-Synthesis Inc
